Dapsone-induced methemoglobinemia : A do
β
Adam J. Esbenshade; Richard H. Ho; Ayumi Shintani; Zhiguo Zhao; Lesley-Ann Smith
π
Article
π
2011
π
John Wiley and Sons
π
English
β 144 KB
## Abstract ## BACKGROUND: Dapsone, used for __Pneumocystis jiroveci__ (PCP) prophylaxis, is associated with increased risk of methemoglobinemia. Absence of cytochrome b5 reductase enzyme activity causes congenital methemoglobinemia, but its role in dapsoneβassociated methemoglobinemia is unknown.